7.0T Magnetic Resonance Imaging Study for Hepatic Encephalopathy

NCT06923254 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-04-11

No results posted yet for this study

Summary

This clinical trial study aims to detect the imaging characteristics of patients with hepatic encephalopathy (HE) using 7-Tesla (7T) magnetic resonance imaging (MRI).

Conditions

  • Hepatic Encephalopathy (HE)
  • MRI
  • fMRI Research

Interventions

OTHER

7.0T MRI-Scan

7.0T MRI-Scan

Sponsors & Collaborators

  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • Xin Lou · Chinese PLA General Hospital

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-03
Primary Completion
2029-12-24
Completion
2030-12-24

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06923254 on ClinicalTrials.gov